We're increasing our Eli Lilly price target after another beat-and-raise quarter

We're increasing our Eli Lilly price target after another beat-and-raise quarter basliginda one cikan gelisme: The strength of its GLP-1 business suggests the stock still has more room to run.

Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.

Orijinal kaynak: CNBC